BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 23434448)

  • 1. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
    Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
    Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
    Ishibashi H; Kobayashi M; Takasaki C; Okubo K
    Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
    Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
    Zellos L; Richards WG; Capalbo L; Jaklitsch MT; Chirieac LR; Johnson BE; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):453-8. PubMed ID: 19185169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
    de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
    Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
    Hod T; Freedberg KJ; Motwani SS; Chen M; Frendl G; Leaf DE; Gupta S; Mothi SS; Richards WG; Bueno R; Waikar SS
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1510-1518. PubMed ID: 32631662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
    Richards WG; Zellos L; Bueno R; Jaklitsch MT; Jänne PA; Chirieac LR; Yeap BY; Dekkers RJ; Hartigan PM; Capalbo L; Sugarbaker DJ
    J Clin Oncol; 2006 Apr; 24(10):1561-7. PubMed ID: 16575008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
    Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Belcher E; Cane P; Landau D; Steele J; Taylor H; Spicer J
    J Thorac Oncol; 2011 Oct; 6(10):1746-52. PubMed ID: 21876457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
    Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
    Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.
    Burt BM; Richards WG; Lee HS; Bartel S; Dasilva MC; Gill RR; Jaklitsch MT; Johnson BE; Swanson SJ; Bueno R; Sugarbaker DJ
    J Thorac Oncol; 2018 Sep; 13(9):1400-1409. PubMed ID: 29753120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma.
    van Ruth S; Baas P; Haas RL; Rutgers EJ; Verwaal VJ; Zoetmulder FA
    Ann Surg Oncol; 2003 Mar; 10(2):176-82. PubMed ID: 12620914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
    Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
    Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.